ArrayExpress is moving to BioStudies. This view of ArrayExpress will be deprecated soon.
Please visit the new experiment page at https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-223.
E-MTAB-223 - ChIP-Seq of human breast cancer cell lines with antibodies FOXA1, ER and CTCF
Released on 1 February 2011, last updated on 30 October 2013
Growth cells and map of ER, FoxA1 and CTCF binding at whole genome level
ChIP-seq, high throughput sequencing, binding site identification
FOXA1 is a key determinant of estrogen receptor function and endocrine response. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. Nat Genet 43(1):27-33 (2011), PMID:21151129
Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties. Serandour AA, Brown GD, Cohen JD, Carroll JS. :R147 (2013), PMID:24373287